2022
Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?
GALUŠKA, David, Lucie DLOUHÁ, Jaroslav HUBÁČEK a Kateřina KAŇKOVÁZákladní údaje
Originální název
Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?
Autoři
GALUŠKA, David (203 Česká republika, domácí), Lucie DLOUHÁ (203 Česká republika, garant), Jaroslav HUBÁČEK (203 Česká republika) a Kateřina KAŇKOVÁ (203 Česká republika, domácí)
Vydání
FOLIA BIOLOGICA, PRAGUE, CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINE, 2022, 0015-5500
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30101 Human genetics
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 0.600
Kód RIV
RIV/00216224:14110/22:00134644
Organizační jednotka
Lékařská fakulta
UT WoS
001010557100001
Klíčová slova anglicky
diabetes mellitus; diabetes complication; polymorphism; Central European population; genetic; GWAS; diabetic neuropathy; diabetic kidney disease; diabetic retinopathy; cardiovascular disease
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 9. 8. 2023 12:06, Mgr. Tereza Miškechová
Anotace
V originále
Type 2 diabetes mellitus (T2DM) is a com-plex disease that has risen in global prevalence over recent decades, resulting in concomitant and enor-mous socio-economic impacts. In addition to the well-documented risk factors of obesity, poor dietary habits and sedentary lifestyles, genetic background plays a key role in the aetiopathogenesis of diabetes and the development of associated micro-and macro -vascular complications. Recent advances in genomic research, notably next-generation sequencing and ge-nome-wide association studies, have greatly improved the efficiency with which genetic backgrounds to com-plex diseases are analysed. To date, several hundred single-nucleotide polymorphisms have been associ-ated with T2DM or its complications. Given the poly -genic background to T2DM (and numerous other complex diseases), the degree of genetic predisposi-tion can be treated as a "continuous trait" quantified by a genetic risk score. Focusing mainly on the Central European population, this review summa-rizes recent state-of-the-art methods that have en-abled us to better determine the genetic architecture of T2DM and the utility of genetic risk scores in dis-ease prediction.
Návaznosti
NV18-01-00046, projekt VaV |
|